ATOSSA THERAPEUTICS, INC. Research and Development Expense
ATOSSA THERAPEUTICS, INC. (ATOS) reported Research and Development Expense of $4.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. research and development expense for the quarter ending 2026-06-30 was $4.90M, a 11.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. research and development expense for the quarter ending 2026-03-31 was $4.78M, a 14.96% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. research and development expense for the quarter ending 2025-12-31 was $6.16M, a 80.90% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. research and development expense for the quarter ending 2025-09-30 was $5.37M, a 57.39% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. research and development expense for fiscal 2025 was $21.18M, a 50.07% increase from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. research and development expense for fiscal 2024 was $14.12M, a 18.56% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. research and development expense for fiscal 2023 was $17.33M, a 14.92% increase from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. research and development expense for fiscal 2022 was $15.08M, a 63.77% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 47 month | Research and Development Expense 50 month | Research and Development Expense 53 month | Research and Development Expense 56 month | Research and Development Expense 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.90M 10-Q · filed 2026-08-07 | $9.68M 10-Q · filed 2026-08-07 | $15.83M derived: sum of 3 quarters · filed 2026-08-07 | $21.20M derived: sum of 4 quarters · filed 2026-08-07 | |||||||||
| 2026-03-31 | $4.78M 10-Q · filed 2026-05-08 | $10.94M derived: sum of 2 quarters · filed 2026-05-08 | $16.30M derived: sum of 3 quarters · filed 2026-05-08 | $21.81M derived: sum of 4 quarters · filed 2026-08-07 | |||||||||
| 2025-12-31 | $6.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $11.53M derived: sum of 2 quarters · filed 2026-03-25 | $17.03M derived: sum of 3 quarters · filed 2026-08-07 | $21.18M 10-K · filed 2026-03-25 | |||||||||
| 2025-09-30 | $5.37M 10-Q · filed 2025-11-12 | $10.87M derived: sum of 2 quarters · filed 2026-08-07 | $15.03M 10-Q · filed 2025-11-12 | $18.43M derived: sum of 4 quarters · filed 2026-08-07 | |||||||||
| 2025-06-30 | $5.50M 10-Q · filed 2026-08-07 | $9.66M 10-Q · filed 2026-08-07 | $13.06M derived: sum of 3 quarters · filed 2026-08-07 | $16.47M derived: sum of 4 quarters · filed 2026-08-07 | |||||||||
| 2025-03-31 | $4.16M 10-Q · filed 2026-05-08 | $7.56M derived: sum of 2 quarters · filed 2026-05-08 | $10.97M derived: sum of 3 quarters · filed 2026-05-08 | $14.53M derived: sum of 4 quarters · filed 2026-05-08 | |||||||||
| 2024-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $6.82M derived: sum of 2 quarters · filed 2026-03-25 | $10.37M derived: sum of 3 quarters · filed 2026-03-25 | $14.12M 10-K · filed 2026-03-25 | |||||||||
| 2024-09-30 | $3.41M 10-Q · filed 2025-11-12 | $6.96M derived: sum of 2 quarters · filed 2025-11-12 | $10.71M 10-Q · filed 2025-11-12 | $16.37M derived: sum of 4 quarters · filed 2025-11-12 | |||||||||
| 2024-06-30 | $3.55M 10-Q · filed 2025-08-12 | $7.30M 10-Q · filed 2025-08-12 | $12.96M derived: sum of 3 quarters · filed 2025-08-12 | $17.42M derived: sum of 4 quarters · filed 2025-08-12 | |||||||||
| 2024-03-31 | $3.75M 10-Q · filed 2025-05-13 | $9.40M derived: sum of 2 quarters · filed 2025-05-13 | $13.87M derived: sum of 3 quarters · filed 2025-05-13 | $17.57M derived: sum of 4 quarters · filed 2025-05-13 | |||||||||
| 2023-12-31 | $5.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $10.12M derived: sum of 2 quarters · filed 2025-03-25 | $13.83M derived: sum of 3 quarters · filed 2025-03-25 | $17.33M 10-K · filed 2025-03-25 | |||||||||
| 2023-09-30 | $4.47M 10-Q · filed 2024-11-12 | $8.17M derived: sum of 2 quarters · filed 2024-11-12 | $11.68M 10-Q · filed 2024-11-12 | $16.67M derived: sum of 4 quarters · filed 2024-11-12 | |||||||||
| 2023-06-30 | $3.71M 10-Q · filed 2024-08-12 | $7.21M 10-Q · filed 2024-08-12 | $12.20M derived: sum of 3 quarters · filed 2024-08-12 | $17.36M derived: sum of 4 quarters · filed 2024-08-12 | |||||||||
| 2023-03-31 | $3.51M 10-Q · filed 2024-05-13 | $8.49M derived: sum of 2 quarters · filed 2024-05-13 | $13.65M derived: sum of 3 quarters · filed 2024-05-13 | $17.09M derived: sum of 4 quarters · filed 2024-05-13 | |||||||||
| 2022-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $10.15M derived: sum of 2 quarters · filed 2024-04-01 | $13.58M derived: sum of 3 quarters · filed 2024-04-01 | $15.08M 10-K · filed 2024-04-01 | |||||||||
| 2022-09-30 | $5.16M 10-Q · filed 2023-11-13 | $8.59M derived: sum of 2 quarters · filed 2023-11-13 | $10.10M 10-Q · filed 2023-11-13 | $11.92M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||
| 2022-06-30 | $3.43M 10-Q · filed 2023-08-14 | $4.94M 10-Q · filed 2023-08-14 | $6.76M derived: sum of 3 quarters · filed 2023-08-14 | $8.96M derived: sum of 4 quarters · filed 2023-08-14 | |||||||||
| 2022-03-31 | $1.50M 10-Q · filed 2023-05-15 | $3.33M derived: sum of 2 quarters · filed 2023-05-15 | $5.53M derived: sum of 3 quarters · filed 2023-05-15 | $9.33M derived: sum of 4 quarters · filed 2023-05-15 | |||||||||
| 2021-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $4.03M derived: sum of 2 quarters · filed 2023-03-22 | $7.83M derived: sum of 3 quarters · filed 2023-03-22 | $9.21M 10-K · filed 2023-03-22 | |||||||||
| 2021-09-30 | $2.21M 10-Q · filed 2022-11-07 | $2.21M 10-Q · filed 2021-11-15 | $6.00M derived: sum of 2 quarters · filed 2022-11-07 | $7.38M 10-Q · filed 2022-11-07 | $7.38M 10-Q · filed 2021-11-15 | $9.74M derived: sum of 4 quarters · filed 2022-11-07 | |||||||
| 2021-06-30 | $3.80M 10-Q · filed 2022-08-08 | $3.80M 10-Q · filed 2021-08-13 | $5.18M 10-Q · filed 2022-08-08 | $5.18M 10-Q · filed 2021-08-13 | $7.54M derived: sum of 3 quarters · filed 2022-08-08 | $9.19M derived: sum of 4 quarters · filed 2022-08-08 | |||||||
| 2021-03-31 | $1.38M 10-Q · filed 2022-05-09 | $1.38M 10-Q · filed 2021-05-14 | $3.74M derived: sum of 2 quarters · filed 2022-05-09 | $5.40M derived: sum of 3 quarters · filed 2022-05-09 | $7.05M derived: sum of 4 quarters · filed 2022-05-09 | ||||||||
| 2020-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $4.02M derived: sum of 2 quarters · filed 2022-02-28 | $5.67M derived: sum of 3 quarters · filed 2022-02-28 | $6.61M 10-K · filed 2022-02-28 | $6.61M 10-K · filed 2021-03-31 | ||||||||
| 2020-09-30 | $1.66M 10-Q · filed 2021-11-15 | $3.31M derived: sum of 2 quarters · filed 2021-11-15 | $4.25M 10-Q · filed 2021-11-15 | $5.15M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||
| 2020-06-30 | $1.65M 10-Q · filed 2021-08-13 | $2.59M 10-Q · filed 2021-08-13 | $3.49M derived: sum of 3 quarters · filed 2021-08-13 | $5.17M derived: sum of 4 quarters · filed 2021-08-13 | |||||||||
| 2020-03-31 | $938.62K 10-Q · filed 2021-05-14 | $1.84M derived: sum of 2 quarters · filed 2021-05-14 | $3.52M derived: sum of 3 quarters · filed 2021-05-14 | $6.13M derived: sum of 4 quarters · filed 2021-05-14 | |||||||||
| 2019-12-31 | $898.02K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $2.58M derived: sum of 2 quarters · filed 2021-03-31 | $5.19M derived: sum of 3 quarters · filed 2021-03-31 | $6.65M 10-K · filed 2021-03-31 | |||||||||
| 2019-09-30 | $1.68M 10-Q · filed 2020-11-13 | $4.30M derived: sum of 2 quarters · filed 2020-11-13 | $5.75M 10-Q · filed 2020-11-13 | $6.60M derived: sum of 4 quarters · filed 2020-11-13 | |||||||||
| 2019-06-30 | $2.61M 10-Q · filed 2020-08-13 | $4.06M 10-Q · filed 2020-08-13 | $4.91M derived: sum of 3 quarters · filed 2020-08-13 | $6.33M derived: sum of 4 quarters · filed 2020-08-13 | |||||||||
| 2019-03-31 | $1.45M 10-Q · filed 2020-05-13 | $2.30M derived: sum of 2 quarters · filed 2020-05-13 | $3.72M derived: sum of 3 quarters · filed 2020-05-13 | $5.19M derived: sum of 4 quarters · filed 2020-05-13 | |||||||||
| 2018-12-31 | $849.42K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $2.27M derived: sum of 2 quarters · filed 2020-03-26 | $3.74M derived: sum of 3 quarters · filed 2020-03-26 | $4.21M 10-K · filed 2020-03-26 | |||||||||
| 2018-09-30 | $1.42M 10-Q · filed 2019-11-13 | $2.89M derived: sum of 2 quarters · filed 2019-11-13 | $3.36M 10-Q · filed 2019-11-13 | $3.58M derived: sum of 4 quarters · filed 2019-11-13 | |||||||||
| 2018-06-30 | $1.47M 10-Q · filed 2019-08-13 | $1.94M 10-Q · filed 2019-08-13 | $2.16M derived: sum of 3 quarters · filed 2019-08-13 | $2.90M derived: sum of 4 quarters · filed 2019-08-13 | |||||||||
| 2018-03-31 | $470.98K 10-Q · filed 2019-05-13 | $688.22K derived: sum of 2 quarters · filed 2019-05-13 | $1.43M derived: sum of 3 quarters · filed 2019-05-13 | $2.25M derived: sum of 4 quarters · filed 2019-05-13 | |||||||||
| 2017-12-31 | $217.24K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $959.69K derived: sum of 2 quarters · filed 2019-03-28 | $1.78M derived: sum of 3 quarters · filed 2019-03-28 | $2.33M 10-K · filed 2019-03-28 | |||||||||
| 2017-09-30 | $742.45K 10-Q · filed 2018-11-14 | $1.57M derived: sum of 2 quarters · filed 2018-11-14 | $2.11M 10-Q · filed 2018-11-14 | $2.48M derived: sum of 4 quarters · filed 2018-11-14 | |||||||||
| 2017-06-30 | $824.09K 10-Q/A · filed 2018-11-13 | $1.37M 10-Q/A · filed 2018-11-13 | $1.73M derived: sum of 3 quarters · filed 2018-11-13 | $1.82M derived: sum of 4 quarters · filed 2018-11-13 | |||||||||
| 2017-03-31 | $544.30K 10-Q · filed 2018-05-14 | $910.77K derived: sum of 2 quarters · filed 2018-05-14 | $995.77K derived: sum of 3 quarters · filed 2018-05-14 | $1.16M derived: sum of 4 quarters · filed 2018-05-14 | |||||||||
| 2016-12-31 | $366.46K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $451.46K derived: sum of 2 quarters · filed 2018-03-08 | $620.46K derived: sum of 3 quarters · filed 2018-03-08 | $770.43K 10-K · filed 2018-03-08 | |||||||||
| 2016-09-30 | $85.00K 10-Q · filed 2017-11-13 | $253.99K derived: sum of 2 quarters · filed 2017-11-13 | $403.96K 10-Q · filed 2017-11-13 | $875.32K derived: sum of 4 quarters · filed 2017-11-13 | |||||||||
| 2016-06-30 | $168.99K 10-Q · filed 2017-08-14 | $318.96K 10-Q · filed 2017-08-14 | $790.32K derived: sum of 3 quarters · filed 2017-08-14 | $1.74M derived: sum of 4 quarters · filed 2017-08-14 | |||||||||
| 2016-03-31 | $149.97K 10-Q · filed 2017-05-11 | $621.33K derived: sum of 2 quarters · filed 2017-05-11 | $1.57M derived: sum of 3 quarters · filed 2017-05-11 | $1.94M derived: sum of 4 quarters · filed 2017-05-11 | |||||||||
| 2015-12-31 | $471.36K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | $1.42M derived: sum of 2 quarters · filed 2017-03-21 | $1.79M derived: sum of 3 quarters · filed 2017-03-21 | $2.36M 10-K/A · filed 2017-03-21 | |||||||||
| 2015-09-30 | $948.96K 10-Q/A · filed 2017-03-21 | $1.09M 10-Q · filed 2015-11-12 | $1.32M derived: sum of 2 quarters · filed 2017-03-21 | $1.89M 10-Q/A · filed 2017-03-21 | $2.40M 10-Q · filed 2015-11-12 | $1.14M derived: sum of 4 quarters · filed 2017-03-21 | |||||||
| 2015-06-30 | $373.47K 10-Q/A · filed 2017-03-21 | $510.46K 10-Q · filed 2015-08-06 | $939.27K 10-Q/A · filed 2017-03-21 | $1.31M 10-Q · filed 2015-08-06 | $193.16K derived: sum of 3 quarters · filed 2017-03-21 | $1.12M derived: sum of 4 quarters · filed 2017-03-21 | |||||||
| 2015-03-31 | $565.80K 10-Q/A · filed 2017-03-21 | $797.23K 10-Q · filed 2015-05-13 | -$180.31K derived: sum of 2 quarters · filed 2017-03-21 | $742.86K derived: sum of 3 quarters · filed 2017-03-21 | $1.25M derived: sum of 4 quarters · filed 2017-03-21 | ||||||||
| 2014-12-31 | -$746.11K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $177.06K derived: sum of 2 quarters · filed 2016-03-30 | $687.83K derived: sum of 3 quarters · filed 2016-03-30 | $1.11M 10-K · filed 2016-03-30 | $2.58M 10-K · filed 2015-03-30 | ||||||||
| 2014-09-30 | $923.17K 10-Q · filed 2015-11-12 | $1.43M derived: sum of 2 quarters · filed 2015-11-12 | $1.86M 10-Q · filed 2015-11-12 | $2.23M derived: sum of 4 quarters · filed 2015-11-12 | |||||||||
| 2014-06-30 | $510.77K 10-Q · filed 2015-08-06 | $933.27K 10-Q · filed 2015-08-06 | $1.31M derived: sum of 3 quarters · filed 2015-08-06 | $1.63M derived: sum of 4 quarters · filed 2015-08-06 | |||||||||
| 2014-03-31 | $422.50K 10-Q · filed 2015-05-13 | $796.36K derived: sum of 2 quarters · filed 2015-05-13 | $1.12M derived: sum of 3 quarters · filed 2015-05-13 | $1.31M derived: sum of 4 quarters · filed 2015-05-13 | $5.08M 10-Q · filed 2014-05-14 | ||||||||
| 2013-12-31 | $373.85K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $694.96K derived: sum of 2 quarters · filed 2015-03-30 | $884.92K derived: sum of 3 quarters · filed 2015-03-30 | $1.11M 10-K · filed 2015-03-30 | $4.66M 10-K · filed 2014-03-27 | ||||||||
| 2013-09-30 | $321.11K 10-Q · filed 2014-11-12 | $511.07K derived: sum of 2 quarters · filed 2014-11-12 | $731.26K 10-Q · filed 2014-11-12 | $1.20M derived: sum of 4 quarters · filed 2014-11-12 | $4.29M 10-Q · filed 2013-11-12 | ||||||||
| 2013-06-30 | $189.96K 10-Q · filed 2014-08-12 | $410.15K 10-Q · filed 2014-08-12 | $875.22K derived: sum of 3 quarters · filed 2014-08-12 | $1.42M derived: sum of 4 quarters · filed 2014-08-12 | $3.97M 10-Q · filed 2013-08-14 | ||||||||
| 2013-03-31 | $220.19K 10-Q · filed 2014-05-14 | $685.26K derived: sum of 2 quarters · filed 2014-05-14 | $1.23M derived: sum of 3 quarters · filed 2014-05-14 | $1.78M derived: sum of 4 quarters · filed 2014-05-14 | $3.78M 10-Q · filed 2013-05-15 | ||||||||
| 2012-12-31 | $465.07K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $1.01M derived: sum of 2 quarters · filed 2014-03-27 | $1.56M derived: sum of 3 quarters · filed 2014-03-27 | $1.97M 10-K · filed 2014-03-27 | |||||||||
| 2012-09-30 | $548.11K 10-Q · filed 2013-11-12 | $1.09M derived: sum of 2 quarters · filed 2013-11-12 | $1.51M 10-Q · filed 2013-11-12 | ||||||||||
| 2012-06-30 | $543.08K 10-Q · filed 2013-08-14 | $961.07K 10-Q · filed 2013-08-14 | |||||||||||
| 2012-03-31 | $417.99K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |